Why the study?
Does conventional RF ablation safely treat incessant and life-threatening supraventricular tachycardias in pregnant women?
Does conventional RF ablation safely treat incessant and life-threatening supraventricular tachycardias in pregnant women?
Conventional RF ablation with strict radioactive dosimeter surveillance and lead shielding can be successfully performed for drug-refractory supraventricular arrhythmias during pregnancy.
Supports feasibility of monitored RF ablation for refractory SVT in pregnancy; leaves open need for prospective safety data before wider use.
Cardiac arrhythmias in pregnant women are a common entity and often drug-refractory. The major concern about using radiofrequency (RF) catheter ablation guided by fluoroscopy to treat arrhythmias during pregnancy is the potential consequences of exposing the fetus to radiation. We present two pregnant patients with incessant and life-threatening supraventricular tachycardias successfully treated by conventional RF ablation under strict radioactive dosimeter surveillance. The availability of better fluoroscopy and lead shielding techniques allows to perform RF ablation of drug-refractory and poorly tolerated supraventricular arrhythmias at any stage of pregnancy, with an appropriate tracking of the radiation dose received by both mother and fetus.
No takes yet. Share an insight, caveat, or question.
Berruezo et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: